Home/Investors/Sanofi

Sanofi

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$3.1B

Focus Areas

4

Top Stage

Commercial

Investment Focus

Infectious Disease Respiratory Diseases Oncology Immunology

Portfolio Companies

Company	Stage	Valuation	Focus
Novavax	Commercial	$1.6B	Infectious Disease, Respiratory Diseases
Nurix Therapeutics	Phase 1	$1.5B	Oncology, Immunology

Frequent Co-Investors

Public shareholders1 shared Serum Institute of India1 shared Coalition for Epidemic Preparedness Innovations (CEPI)1 shared U.S. Government (via Operation Warp Speed)1 shared Gilead Sciences1 shared